Multiplex Biomarker Imaging Market Information, Figures and Analytica Multiplex Biomarker Imaging Healthcare | Page 5

Multiplex Biomarker Imaging Market
Multiplex Biomarker Imaging Market:Overview
Multiplex biomarker imaging market is highly fragmented as the players in this segment are having a vast
range of product like (Vectra 3.0 for 6 to 200 slides from PerkinElmer Inc). Multiplex biomarker imaging
provides a successful identification and validation of clinical data related to immune cells, csssancer cells.
IHC (immunohistochemistry) is used to identify and co-localize antigens in cell and tissue, but the
validation of IHC assay has undertaken by using TMA (Tissue microarray). So as the modern research will
be using the TMA as its enables high throughput tissue analysis, up to 1000 minute tissue sample are
brought into array format and analysis. TMA is much faster and cost effective as of other techniques.
Request For Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3526
Multiplex Biomarker Imaging Market:Region-wise Outlook
Geographically, multiplex biomarker imaging market is segmented into North America, Latin America,
Western Europe, Eastern Europe, Asia Pacific, Japan, Middle East and Africa. Asia pacific will be the
growing market as the research is going on for the treatment in chronic disease (cancer, tumor). As per
WHO 8.2 million people die in 2015 due to cancer, this motives the industry for more growth in Asia-
pacific in terms of research using multiplex biomarker imaging for pre-diagnosis
©2015 Future Market Insights, All Rights Reserved
5